Literature DB >> 6291761

Comparative studies on the quantitative analysis of experimental metastatic capacity.

I R Hart, J E Talmadge, I J Fidler.   

Abstract

The purpose of these studies was to establish a procedure for determining the relative experimental metastatic potential of unrelated murine tumors. We used three tumors (the B16-F10 melanoma, which is syngeneic to the C57BL/6N mouse, and the K-1735 melanoma and the UV-2237 fibrosarcoma, which are syngeneic to the C3H/HeN mouse). Various numbers of tumor cells were injected into normal or immunosuppressed syngeneic recipients and into 3-week-old BALB/c nude mice. At appropriate intervals, the recipient mice were killed, and the metastatic burden was determined. The number of experimental metastases was not linearly correlated with cell input. Thus, simply comparing the incidence of metastasis resulting from the injection of one predetermined dose of tumor cells did not allow for determination of their relative metastatic capacities. More reproducible and meaningful results were obtained by introducing increasing numbers of viable tumor cells admixed with a constant number of nontumorigenic (X-irradiated) tumor cells serving as carrier. The incidence of metastasis by few or many injected cells is influenced by host factors such as immune status, and therefore determinations of the true metastatic nature of any given tumor necessitate the choice of an appropriate recipient.

Entities:  

Mesh:

Year:  1983        PMID: 6291761

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Enhancement of lung colony formation by admixing irradiated with viable tumor cells: dependence on host status.

Authors:  L Milas; M Iwakawa; N Hunter
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

2.  Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy.

Authors:  Judy R van Beijnum; Elisabeth J M Huijbers; Karlijn van Loon; Athanasios Blanas; Parvin Akbari; Arno Roos; Tse J Wong; Stepan S Denisov; Tilman M Hackeng; Connie R Jimenez; Patrycja Nowak-Sliwinska; Arjan W Griffioen
Journal:  Nat Commun       Date:  2022-05-23       Impact factor: 17.694

3.  Evaluation of metastatic ability at specific times during primary tumor growth: a novel spontaneous metastasis assay.

Authors:  Y Takiguchi; T Kuriyama; T Miyamoto
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

4.  Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs.

Authors:  T J McMillan; I R Hart
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

5.  Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells.

Authors:  Y Hashimoto; N Shindo-Okada; M Tani; Y Nagamachi; K Takeuchi; T Shiroishi; H Toma; J Yokota
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

6.  In vivo characterization of a doxorubicin resistant B16 melanoma cell line.

Authors:  F Formelli; C Rossi; R Supino; G Parmiani
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.